Medicare Enrolled

Dr. Daisy Borroto Conde, MD

Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8700 W FLAGLER ST STE 420, Miami, FL 33174
3056080656
In practice since 2009 (17 years)
NPI: 1932341104 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Borroto Conde from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borroto Conde? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Borroto Conde

Dr. Daisy Borroto Conde is a neurology in Miami, FL, with 17 years in practice. Based on federal Medicare data, Dr. Borroto Conde performed 431 Medicare services across 315 unique beneficiaries.

Between the years covered by Open Payments, Dr. Borroto Conde received a total of $1,916 from 23 pharmaceutical and/or device companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Borroto Conde is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ 431 Medicare services$ $1,916 industry payments

Medicare Practice Summary

Medicare Utilization ↗
431
Medicare services
Bottom 45% in FL for neurology
315
Unique beneficiaries
$155
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)238$105$200
Measurement of brain wave activity (eeg), awake and drowsy59$313$462
Measurement of brain wave activity (eeg), digital analysis58$227$400
New patient office visit (45-59 min)51$139$350
Exam of neurobehavioral status, first hour14$77$160
Nerve conduction, 11-12 studies11$198$450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,916
Total received (2018-2024)
Avg $274/year across 7 years
Bottom 49% in FL for neurology
23
Companies
111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,916 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$477
2023
$338
2022
$273
2021
$85
2020
$14
2019
$106
2018
$624

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$362
ABBVIE INC.
$209
Teva Pharmaceuticals USA, Inc.
$183
Abbott Laboratories
$159
ACADIA Pharmaceuticals Inc
$152
UCB, Inc.
$142
Supernus Pharmaceuticals, Inc.
$133
Otsuka America Pharmaceutical, Inc.
$86
Sunovion Pharmaceuticals Inc.
$69
Amneal Pharmaceuticals LLC
$52
EISAI INC.
$51
Catalyst Pharmaceuticals, Inc.
$50
AbbVie Inc.
$48
CATALYST PHARMACEUTICALS, INC.
$45
Allergan, Inc.
$38
Sumitomo Pharma America, Inc.
$28
Lilly USA, LLC
$21
Adamas Pharmaceuticals, Inc.
$18
Novartis Pharmaceuticals Corporation
$17
Aprecia Pharmaceuticals, LLC
$17
Amgen Inc.
$16
Upsher-Smith Laboratories LLC
$13
Impax Laboratories, Inc.
$11
Top 3 companies account for 39.3% of total payments
Associated products mentioned in payments ›
AJOVY · AMYVID · APTIOM · AUSTEDO · Aimovig · Austedo XR · BOTOX · FYCOMPA · Fycompa · GOCOVRI · INGREZZA · Infinity DBS Pulse Generators · MAYZENT · NUPLAZID · Ongentys · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Spritam · TROKENDI XR · UBRELVY · Vimpat
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $445 per 100 Medicare services performed
Looking for a neurology in Miami?
Compare neurologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
280
Per 100K population
10.4
County median income
$68,694
Nearest hospital
HCA FLORIDA KENDALL HOSPITAL
3.4 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data✓ Medicare Util.Annual (CY lag)
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Borroto Conde is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Borroto Conde experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Borroto Conde performed 238 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borroto Conde receive payments from pharmaceutical companies?
Yes. Dr. Borroto Conde received a total of $1,916 from 23 companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borroto Conde's costs compare to other neurologys in Miami?
Dr. Borroto Conde's average Medicare payment per service is $155. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borroto Conde) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Miami
Browse neurologys in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →